分次调强放疗在多学科管理原发性视神经鞘脑膜瘤中的回顾性分析
该回顾性分析纳入26例仅累及眶内和视神经管的单侧原发性视神经鞘脑膜瘤患者,均接受统一的分次调强放疗方案(GTV+2mm/5mm,54Gy/51Gy,分次1.8Gy/1.7Gy)。结果显示首次随访时视力和视野显著改善,长期16例视力改善、6例稳定、4例下降,其中2例下降被多学科讨论归因于放疗。结论认为严格筛选下放疗安全且能显著改善视功能。
要点
- 严格筛选的单侧原发性ONSM患者接受51Gy/54Gy分次IMRT后视功能显著改善。
- 长期随访16例视力改善、6例稳定、4例下降,仅2例下降归因于放疗。
- 多学科治疗决策和放疗团队经验对疗效与安全性至关重要。
核心结论
- 严格筛选的单侧原发性视神经鞘脑膜瘤患者接受51Gy/54Gy分次调强放疗是安全的,并导致视功能显著改善。
研究设计与样本
- 回顾性分析纳入26例单侧视神经鞘脑膜瘤患者,肿瘤仅延伸至眶内和视神经管,所有患者接受统一的分次调强放疗方案。
主要发现
- 首次治疗后随访时视力和视野均显著改善,视力改善也见于治疗前存在严重缺陷的患者。
- 长期评估显示16例患者视功能改善,6例稳定,4例视功能下降。
- 多学科病例讨论将2例患者的视功能下降评定为与放疗相关。
关键数值与推荐
- 放疗采用同步整合推量方案:GTV+2mm处方54Gy,分次1.8Gy;GTV+5mm处方51Gy,分次1.7Gy。
- 放疗计划评估包括等效均匀剂量(EUD)和视神经最大剂量。
临床怎么用
- 对严格筛选的单侧原发性视神经鞘脑膜瘤患者,可考虑采用51Gy/54Gy分次调强放疗以改善视功能。
- 治疗决策应经多学科讨论,并重视放疗团队的经验积累。
局限性
- 本文为回顾性分析,样本量26例,无前瞻性对照。
- 视功能下降的放疗归因基于多学科讨论的主观评定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As optic nerve sheath meningiomas (ONSM) are rare, there are no prospective studies. Our retrospective analysis focusses on a cohort of patients with uniform disease characteristics all treated with the same radiotherapy regimen. We describe treatment decision making, radiotherapy planning and detailed neuro-ophthalmological outcome of the patients. METHODS: 26 patients with unilateral ONSM extending only to the orbit and the optic canal were evaluated for neuro-ophthalmological outcome. Radiation treatment was planned in a simultaneous integrated boost approach to gross tumor volume (GTV) + 2 mm / 5 mm to 54 Gy / 51 Gy in 1.8 Gy / 1.7 Gy fractions. Follow-up was done by specialized neuro-ophthalmologists. Visual acuity and visual field defects were evaluated after therapy as well as during follow-up. RESULTS: Interdisciplinary treatment decision for patients with ONSM follows a rather complex decision tree. Radiation treatment planning (equivalent uniform dose (EUD), maximum dose to the optic nerve) improved with experience over time. With this patient selection visual acuity as well as visual field improved significantly at first follow-up after treatment. For visual acuity this also applied to patients with severe defects before treatment. Long term evaluation showed 16 patients with improved visual function, 6 were stable, in 4 patients visual function declined. Interdisciplinary case discussion rated the visual decline as radiation-associated in two patients. CONCLUSIONS: With stringent patient selection radiotherapy for unilateral primary ONSM to 51 Gy / 54 Gy is safe and leads to significantly improved visual function. Interdisciplinary treatment decision and experience of the radiation oncology team play a major role.
引用
- Eckert F, Clasen K, Kelbsch C, et al. Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas. Radiat Oncol. 2019. PMID: 31881902. doi:10.1186/s13014-019-1438-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。